Go Pro
NYSE:PBH

Prestige Consumer Healthcare (PBH) Stock Price, News & Analysis

Prestige Consumer Healthcare logo
$49.98 -2.21 (-4.23%)
Closing price 03:59 PM Eastern
Extended Trading
$49.94 -0.04 (-0.09%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Prestige Consumer Healthcare Stock (NYSE:PBH)

Advanced

Key Stats

Today's Range
$49.78
$51.09
50-Day Range
$45.43
$52.17
52-Week Range
$42.62
$75.63
Volume
392,328 shs
Average Volume
449,016 shs
Market Capitalization
$2.37 billion
P/E Ratio
12.78
Dividend Yield
N/A
Price Target
$70.75
Consensus Rating
Hold

Company Overview

Prestige Consumer Healthcare, Inc. is a leading manufacturer and marketer of branded over-the-counter (OTC) healthcare products. The company focuses on developing, acquiring and commercializing a diverse portfolio of non-prescription remedies designed to address common consumer health needs, including pain relief, cold and cough, digestive health, eye care, skin care and women’s health.

Key brands in Prestige’s portfolio include Clear Eyes (eye health), Carmex (lip care), Chloraseptic (sore throat relief), Dramamine (motion sickness), Rolaids (antacid), Monistat (women’s health), BC Powder (pain relief), Little Remedies (pediatric cold and gas relief) and TheraTears (dry eye therapy). Prestige distributes its products primarily in the United States and Canada through supermarket, drug store, mass merchandise, dollar, club and e-commerce channels, and selectively in other markets through export partnerships.

Formed through a series of strategic acquisitions of established consumer healthcare names, Prestige Consumer Healthcare has grown by integrating well-known OTC brands under a centralized commercial and operational platform. The company is headquartered in Tarrytown, New York, and leverages a focused R&D and regulatory support team to drive incremental innovation across its brand portfolio. Tony Long has served as President and Chief Executive Officer since December 2019, leading initiatives to expand Prestige’s market presence and enhance its category leadership.

AI Generated. May Contain Errors.

Prestige Consumer Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
83rd Percentile Overall Score

PBH MarketRank™: 

Prestige Consumer Healthcare scored higher than 83% of companies evaluated by MarketBeat, and ranked 60th out of 832 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Prestige Consumer Healthcare has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 2 buy ratings, 2 hold ratings, and 2 sell ratings.

  • Upside Potential

    Prestige Consumer Healthcare has a consensus price target of $70.75, representing about 41.6% upside from its current price of $49.98.

  • Amount of Analyst Coverage

    Prestige Consumer Healthcare has only been the subject of 4 research reports in the past 90 days.

  • Read more about Prestige Consumer Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for Prestige Consumer Healthcare are expected to grow by 5.39% in the coming year, from $4.45 to $4.69 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Prestige Consumer Healthcare is 12.78, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 43.85.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Prestige Consumer Healthcare is 12.78, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 22.76.

  • Price to Earnings Growth Ratio

    Prestige Consumer Healthcare has a PEG Ratio of 1.68. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Prestige Consumer Healthcare has a P/B Ratio of 1.25. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Prestige Consumer Healthcare's valuation and earnings.
  • Percentage of Shares Shorted

    6.62% of the float of Prestige Consumer Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Prestige Consumer Healthcare has a short interest ratio ("days to cover") of 6.65.
  • Change versus previous month

    Short interest in Prestige Consumer Healthcare has recently decreased by 3.92%, indicating that investor sentiment is improving.
  • Dividend Yield

    Prestige Consumer Healthcare does not currently pay a dividend.

  • Dividend Growth

    Prestige Consumer Healthcare does not have a long track record of dividend growth.

  • Dividend Sustainability

    Based on earnings estimates, Prestige Consumer Healthcare will have a dividend payout ratio of 40.51% next year. This indicates that Prestige Consumer Healthcare will be able to sustain or increase its dividend.

  • News Sentiment

    Prestige Consumer Healthcare has a news sentiment score of 1.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.89 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Prestige Consumer Healthcare this week, compared to 4 articles on an average week.
  • Search Interest

    5 people have searched for PBH on MarketBeat in the last 30 days. This is an increase of 67% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Prestige Consumer Healthcare to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Prestige Consumer Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $85,514.00 in company stock.

  • Percentage Held by Insiders

    1.50% of the stock of Prestige Consumer Healthcare is held by insiders.

  • Percentage Held by Institutions

    99.95% of the stock of Prestige Consumer Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Prestige Consumer Healthcare's insider trading history.
Receive PBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prestige Consumer Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PBH Stock News Headlines

Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
See More Headlines

PBH Stock Analysis - Frequently Asked Questions

Prestige Consumer Healthcare's stock was trading at $61.69 at the beginning of 2026. Since then, PBH shares have decreased by 19.0% and is now trading at $49.98.

Prestige Consumer Healthcare Inc. (NYSE:PBH) announced its quarterly earnings results on Wednesday, May, 13th. The company reported $1.23 earnings per share for the quarter, missing analysts' consensus estimates of $1.39 by $0.16. Prestige Consumer Healthcare's quarterly revenue was down 5.0% compared to the same quarter last year.
Read the conference call transcript
.

Top institutional investors of Prestige Consumer Healthcare include Wedge Capital Management L L P NC (0.13%), PensionDanmark Pensionsforsikringsaktieselskab (0.04%), GAMMA Investing LLC (0.01%) and Versant Capital Management Inc. Insiders that own company stock include Ronald M Lombardi, Jeffrey Zerillo, William P'pool, Adel Mekhail and Mary Beth Fritz.
View institutional ownership trends
.

Shares of PBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Prestige Consumer Healthcare investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), The RMR Group (RMR), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR) and AUO (AUOTY).

Company Calendar

Last Earnings
5/13/2026
Today
7/30/2026
Next Earnings (Estimated)
8/06/2026
Fiscal Year End
3/31/2027

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Personal Products
Current Symbol
NYSE:PBH
CIK
1295947
Employees
540
Year Founded
1996

Price Target and Rating

High Price Target
$80.00
Low Price Target
$65.00
Potential Upside/Downside
+41.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
$3.91
Trailing P/E Ratio
12.78
Forward P/E Ratio
11.23
P/E Growth
1.68
Net Income
$190.30 million
Net Margins
17.48%
Pretax Margin
23.65%
Return on Equity
11.54%
Return on Assets
6.16%

Debt

Debt-to-Equity Ratio
0.54
Current Ratio
3.57
Quick Ratio
2.25

Sales & Book Value

Annual Sales
$1.09 billion
Price / Sales
2.17
Cash Flow
$4.99 per share
Price / Cash Flow
10.02
Book Value
$39.89 per share
Price / Book
1.25

Miscellaneous

Outstanding Shares
47,370,000
Free Float
46,661,000
Market Cap
$2.37 billion
Optionable
Optionable
Beta
0.35

Social Links

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (NYSE:PBH) was last updated on 7/30/2026 by MarketBeat.com Staff.
From Our Partners